cGvHD
Action Outputs
The main aim and objective of the Action is to establish a European Network to further understand chronic GvHD, through networking and interdisciplinary training.
Poster Presentations
|
1. European Society for Blood and Marrow Transplantation 46th annual meeting 2020, Madrid, Spain Incidence of chronic Graft-versus-Host Disease – results from a prospective multicentre analysis of 2 cohorts. A. Lelas, R. Langer, M. Rittenschober, L. Desnica, H.Greinix, A. Dickinson, M. Inngjerdingen, A. Lawitschka, R.Vrhovac, D. Pulanic, S. Klein, J.M. Middeke, M. Edinger, D. Wolff |
|
|
2. European Society for Blood and Marrow Transplantation 46th annual meeting 2020, Madrid, Spain Practice patterns in chronic GVHD patient management and patient reported outcome measures across the EBMT Allogenic Transplantation Network. Ivan Sabol, Vladimir Perovic, Magdalena Grce, Marit Inngjerdingen, Drazen Pulanic, Christophe Peczynski, Emmanuelle Polge, Zinaida Peric, Christian Koenecke, Anne Dickinson, Hildegard Greinix, Grzegorz Basak, Olaf Penack, Angela Scherwath, Anna Barata, Attilio Olivieri, Anita Lawitschka, Patrycja Mensah-Glanowska, Hajnalka Andrikovics, Miklos Laszlo Udvardy, Helene Schoemans, Daniel Wolff |
Oral Presentations
|
Differential expression of miRNAs in chronic Graft-versus-Host Disease. K. Bogunia-Kubik, P. Lacina1, R. E. Crossland, J. Wielińska, A. Czyż, M. Ussowicz, T. Wróbel, A. Dickinson |
Publications
|
1. Neutrophils cause a "NET" increase in skin allograft allogenicity Brouard S, Mooney N. Am J Transplant. 2019 Dec 17. doi: 10.1111/ajt.15746. [Epub ahead of print] |
|
|
A Systematic Review of Patient Reported Outcome Measures in Graft-versus-Host-Disease (GVHD) Kilgour DJ, Wali DG, Gibbons ME, Scherwath DA, Badiella DAB, Peniket DA, Schoemans DH, Matin DRN. Biol Blood Marrow Transplant. 2020 Feb 3. pii: S1083-8791(20)30055-0. doi: 10.1016/j.bbmt.2020.01.022. [Epub ahead of print] |
See Also
Find out more about the Action by exploring the site links on the right hand side.
